Board Members


Jon Hindar

Chairman                                                        .

  • In-house advisor to Summa Equity
  • Former CEO of Cermaq Group, Norsun and Dynal
  • Board positions in several companies
  • Previously SVP at Invitrogen

MSc in Chemistry from NTNU in Trondheim, Norway and PED from IMD in Lausanne, Switzerland

 _________________________________________________________________________

Fred S. Apple

Board Member

Dr. Apple has served as a Non-Executive Director at HyTest since 2016. Dr. Apple is Medical Director of Clinical Laboratories at Hennepin County Medical Center in Minneapolis, Minnesota, and Professor of Laboratory Medicine and Pathology at the University of Minnesota School of Medicine, Minnesota, USA.

He is one of the key opinion leaders in the field of cardiovascular disease biomarker research. Furthermore, he has either authored or co-authored over 250 scientific papers and has served as an Associate Editor of Clinical Chemistry for over 20 years.

Dr. Apple is a member of the ‘AACC Academy/National Academy of Clinical Biochemistry’ Laboratory Practice committee, the ‘Global Task Force of the Universal Definition of Myocardial Infarction’, the ‘Institute of Medicine’s Committee on Qualification of Biomarkers as Surrogate Endpoints of Chronic Disease Risk’, the ’NHLBI Working Group for Onsite Tools and Technologies for Clinical Cardiovascular Research and Point-of-Care Testing’, and is the Chair of the IFCC "Committee on Clinical Application of Cardiac Biomarkers ", all which have been instrumental in establishing clinical and laboratory practice guidelines for the use of biomarkers for acute coronary syndromes and heart failure. 

Possessing broad experience in cardiac diagnostics as a clinicial scientist and as a highly respected researcher, Professor Apple brings important insights to the HyTest Board of Directors.

 _________________________________________________________________________

Nick Roelofs, Industrial Advisor

Board Member

  • 25 years experience in Healthcare and the field of medical technologies, devices, and Life Science/Diagnostics
  • Member of multiple boards within life science, and previously senior roles within organisations such as Agilent, Bio-Rad, Stratagene, Applied Biosystems and Baxter

 

 _________________________________________________________________________

Volker Pfahlert, Industrial Advisor

Board Member

  • CEO of numares AG
  • Former CEO for Dräger Medical
  • Former Head of Professional Diagnostics at Roche Diagnostics
  • Several board positions in life sciences companies

 

 

 

  _________________________________________________________________________

Tommi Unkuri

Board Member

  • Co-founder of Summa Equity
  • Responsible for the investments in IVBAR and Lin Education
  • Background from Nordic Capital, with a full-time focus on global healthcare investments, and Morgan Stanley

 

.

 

 

  _________________________________________________________________________

Maria Severina

Board Member

Dr. Severina is the Managing Director of HyTest. Prior to joining HyTest, she worked as a Senior Researcher at the Moscow State University and she moved to Finland in order to join Hybritest project at the University of Turku in 1993. In 1994, Hybritest was reorganized as a company named HyTest Ltd. and Dr. Severina was appointed as the Managing Director. Under her supervision, HyTest has developed from a startup company into one of the key suppliers of high quality raw materials to the global IVD industry.

Dr. Severina holds a PhD in Biochemistry and Immunochemistry from the Lomonosov Moscow State University.

 _________________________________________________________________________